<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="66968">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01690039</url>
  </required_header>
  <id_info>
    <org_study_id>090/12</org_study_id>
    <nct_id>NCT01690039</nct_id>
  </id_info>
  <brief_title>Influence of Polymorphisms in the ATP6V1 Gene of the V-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis</brief_title>
  <official_title>Prospective Clinical Study About the Influence of Polymorphisms in the ATP6V1 Gene of the Vacuolar-type H+-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis in Patients With Recurrent Nephrolithiasis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The V-ATPase proton pump on the luminal membrane of α-intercalated cells is critical for
      urinary acidification. To study the impact of polymorphisms in the ATP6V1 gene on
      acidification in humans in vivo patients with nephrolithiasis will be enrolled in our renal
      stone registry database and will undergo an intensive metabolic investigation. Exons of the
      ATP6V1 gene will be sequenced and urinary acidification will be assessed.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>capability of urinary acidification</measure>
    <time_frame>five to six hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>polymorphisms in the ATP6V1 gene</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Acidosis, Renal Tubular</condition>
  <condition>Nephrolithiasis</condition>
  <condition>Vacuolar Proton-Translocating ATPases</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Furosemide-Fludrocortisone-Test and Ammonium chloride-Loading Test will be performed in renal stone patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Furosemide-Fludrocortisone-Test (test for urinary acidification)</intervention_name>
    <description>The presence of a lack of urinary acidification will be assessed by an appropriate test in all patients.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Application of Furosemide (Lasix® ) and Fludrocortisone (Florinef®)</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients suffered from at least one kidney stone episode.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  one or more episodes of nephrolithiasis

        Exclusion Criteria:

          -  absence of informed consent

          -  all conditions affecting renal acidification

          -  pregnancy

          -  nursing
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Fuster, Attending physician Nephrology</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Nephrology and Hypertension, Bern University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel Fuster, Attending physician Nephrology</last_name>
    <phone>++41 (0)31 631 37 49</phone>
    <email>daniel.fuster@ibmm.unibe.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nasser Dhayat, Resident Nephrology</last_name>
    <phone>++41 (0)31 632 31 44</phone>
    <email>nasser.dhayat@insel.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Nephrology and Hypertension, Bern University Hospital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Fuster Daniel, Attending physician Nephrology</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nasser Dhayat, Resident Nephrology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://www.nephrologie.insel.ch/</url>
    <description>Institution homepage</description>
  </link>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 28, 2014</lastchanged_date>
  <firstreceived_date>September 10, 2012</firstreceived_date>
  <responsible_party>
    <name_title>PD Dr. med. Daniel Fuster</name_title>
    <organization>University of Bern, Departement of Nephrology and Hypertension</organization>
  </responsible_party>
  <keyword>renal tubular acidosis</keyword>
  <keyword>V-ATPase</keyword>
  <keyword>kidney stones</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acidosis</mesh_term>
    <mesh_term>Acidosis, Renal Tubular</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fludrocortisone</mesh_term>
    <mesh_term>Furosemide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
